Type your tag names separated by a space and hit enter

    Artesunate

    Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D. BCPS
    Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
    Artesunate is a topic covered in the Johns Hopkins ABX Guide.

    To view the entire topic, please or purchase a subscription.

    Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

    Johns Hopkins Guides

    -- The first section of this topic is shown below --

    INDICATIONS

    FDA

    • FDA approved only artemether-lumefantrine combination (see this module for details).
      • Artesunate (as single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.

    NON-FDA APPROVED USES

    • Mild to moderate malaria falciparum.

    -- To view the remaining sections of this topic, please or purchase a subscription --

    Last updated: October 2, 2018

    Citation

    * When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
    TY - ELEC T1 - Artesunate ID - 540033 A1 - Dzintars,Kathryn,Pharm.D., BCPS AU - Pham,Paul,Pharm.D. BCPS Y1 - 2018/10/02/ BT - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540033/all/Artesunate PB - The Johns Hopkins University DB - Johns Hopkins Guide DP - Unbound Medicine ER -